Speakers

Expand/Collapse

Christopher Vitale
Senior Engineer, API Pilot Plant
AbbVie

 

Pre-Conference Focus Day

Tuesday January 28, 2020

10:30 am | Group Discussion: Facility Design for the Implementation of Continuous Processing

10:00 am | Facility Design for Continuous Manufacturing Laboratories and Clinical Supply Facilities

Richard Steiner
Global Sales Director for Continuous Processing Technologies
GEA Pharma Systems

Stream 1 - Day 2

1:45 pm | Continuous Manufacturing, the enabling technology for the Digital Pharma initiative within the framework of Industry4.0

Karol Lacki
VP Technology Development
Avitide

Stream 2 - Day 1 PM

1:30 pm | Continuous manufacturing of agarose resins and its applications

Madiha Khurshid
Senior Associate Scientist
Amgen

Day One

Wednesday 29th January 2020

5:00 pm | Celebrating Half a Decade of CCP: Evening Reception Including Panel Discussion on Diversity in Pharma Manufacturing

Stream 2 - Day 2

1:15 pm | Continuous Manufacturing Enables Improved Productivity in Biologics Manufacturing

Navin Tiwari
Head of Digital Shop Floor Automation
Sanofi

Pre-Conference Focus Day

Tuesday January 28, 2020

3:30 pm | Sanofi’s Massachusetts Digital Facility Delivering a Continuous Process

Armin Opitz
Director, MSAT (Manufacturing Science and Technology)
Sanofi

Pre-Conference Focus Day

Tuesday January 28, 2020

3:30 pm | Sanofi’s Massachusetts Digital Facility Delivering a Continuous Process

Moiz Diwan
Director, Head of Enabling Technology Group
AbbVie

Day One

Wednesday 29th January 2020

9:45 am | Panel Discussion: Where’s the Real Barrier to CM Implementation; Regulatory, Strategic or Economic?

Stream 1 - Day 1 AM

11:30 am | FAST Impact Towards Efficient Biopharmaceutical Process Development & Manufacturing

Jeroen Geens
Scientific Director, Drug Product Development
Janssen R&D

Andrew Falconbridge
Vice President Process Technology & Innovation
Alvotech

Stream 2 - Day 2

1:45 pm | Hybrid Model for Continuous Processing of Biosimilars in a Commercial Environment

Flavien Susanne
Head of Chemical Development and Engineering
Sanofi

Day One

Wednesday 29th January 2020

9:45 am | Panel Discussion: Where’s the Real Barrier to CM Implementation; Regulatory, Strategic or Economic?

Pre-Conference Focus Day

Tuesday January 28, 2020

4:15 pm | Group Discussion: Revolutionizing Your Regulatory Strategy

Stream 1 - Day 1 AM

11:00 am | Sanofi’s Journey & Strategy for Continuous Processing for Small Molecules

Richard Ding
Director, Downstream Process Development Manufacturing
AnaptysBio

Stream 1 - Day 2

2:15 pm | CMC Considerations for an End-to-End Continuous Bioprocess From Design to Application

Stream 2 - Day 2

2:15 pm | CMC Considerations for an End-to-End Continuous Bioprocess From Design to Application

Adam Clarke
Process Engineer
AstraZeneca

Day Two

Thursday January 30, 2020

10:30 am | Application of Continuous Processing to Go Green & Meet Sustainability Goals

Pre-Conference Focus Day

Tuesday January 28, 2020

11:30 am | Presentation and Group Discussion on Capability Building for CM & Scale up

Ronald Maurer
Principal Scientist, Downstream Process Development
Bristol-Myers Squibb

Day One

Wednesday 29th January 2020

9:45 am | Panel Discussion: Where’s the Real Barrier to CM Implementation; Regulatory, Strategic or Economic?

Nick Thomson
Senior Director, Chemical Research & Development
Pfizer Inc.

Nick graduated from the University of Edinburgh with a BSc (Hons) in Environmental Chemistry before completing a PhD in organic synthesis under Prof. Gerry Pattenden at the University of Nottingham.   Nick worked briefly at Zeneca Fine Chemicals Manufacturing Organization, Grangemouth (UK) and joined Pfizer in 1997 as a synthetic chemist in Process Research & Development.  Nick spent his early Pfizer career in the evolving process chemistry departments in Sandwich (UK), Sittingbourne (UK) and Holland, Michigan (USA).  From 2005 to 2010, Nick led the Sandwich Research Active Pharmaceutical Ingredient (API) department, with accountability for delivery of API technology from lead development to proof of concept.  In 2011, Nick joined the Pfizer Chemical Research and Development department in Groton, Connecticut (USA), as a Director of API Process Chemistry Laboratories, with accountability for the Quality by Design development and submission of late stage candidates.  In 2014, Nick became head of the Technology API line for Pfizer Chemical Research and Development, with accountability for Technology Strategy, High Throughput Screening, Biocatalysis and Flexible API Supply Technologies (Continuous).  Nick has been active in cross pharmaceutical precompetitive collaboration, as Chair of the IQ API Leadership Team and a board member of the Enabling Technologies Consortium.

Day One

Wednesday 29th January 2020

5:00 pm | Celebrating Half a Decade of CCP: Evening Reception Including Panel Discussion on Diversity in Pharma Manufacturing

Tiago Vieira
Director, Process Development
Gilead Sciences

Day Two

Thursday January 30, 2020

4:30 pm | Contingency Planning Panel Discussion

Stream 1 - Day 1 PM

1:45 pm | Development of a Large-Scale Cyanation Process Using Continuous Flow Chemistry En Route to the Synthesis of Remdesivir

Letha Chemmalil
Principal Scientist
Bristol-Myers Squibb

Stream 2 - Day 1 AM

11:30 am | PAT Tools for Supporting QbD-Based Continuous Bioprocessing

Oliver Thiel
Executive Director Process Development
Amgen

Day Two

Thursday January 30, 2020

11:45 am | Fire Side Chat: What Is the Optimum Length for a Continuous Train?

Matthew Beaver
Senior Scientist – Process Development
Amgen

Stream 1 - Day 1 AM

12:00 pm | The Role of Continuous Manufacturing to Advance Amgen’s Synthetic Portfolio

Jon Coffman
Senior Director of Bioprocess Technologies
AstraZeneca

Stream 2 - Day 1 PM

1:50 pm | A Common Framework for Integrated & Continuous Bioprocessing

Dejan Arzensek
Principal Scientist
Novartis

Pre-Conference Focus Day

Tuesday January 28, 2020

10:30 am | Group Discussion: Facility Design for the Implementation of Continuous Processing

Stream 2 - Day 1 AM

11:00 am | Implementing a Quality by Design (QbD) Approach in Integrated DSP Using In-line PAT Advanced Analytical Technologies to Monitor Critical Quality Attributes

Celia Cruz
Senior Director
Eli Lilly

Day Two

Thursday January 30, 2020

11:45 am | Fire Side Chat: What Is the Optimum Length for a Continuous Train?

Stream 1 - Day 2

1:15 pm | Continuous Manufacturing to Enable New Modalities

Christos Varsakelis
Team Lead Artificial Intelligence/Machine Learning Compound Profiling, Janssen
Janssen

Day One

Wednesday 29th January 2020

4:15 pm | A Holistic Approach to the Industry 4.0 Investment Agenda: Breaking Down the Fences Between R&D & Manufacturing

Ruth Hardy
Director Chemical Research
Pfizer

Day Two

Thursday January 30, 2020

4:30 pm | Contingency Planning Panel Discussion

10:00 am | Exploiting Modularization for Flexible Manufacturing

Sarah Pope Miksinski
Senior Director, Global Regulatory Affairs
AstraZeneca

Day One

Wednesday 29th January 2020

9:15 am | Integration Regulatory Teams in Industry CM Process Development

Jean-Marc Bielser
Associate Manager. Technology & Innovation
Merck Group

Stream 2 - Day 1 AM

12:00 pm | Development & Implementation of Continuous Technologies for Biotherapeutics – An Overview

Sean Daughtry
Director Technical Operations
Vertex

Day Two

Thursday January 30, 2020

4:30 pm | Contingency Planning Panel Discussion

4:00 pm | Challenges and Improvements in CMO PAT Tech Transfer

Nima Yazdanpanah
Advanced Manufacturing Consultant
Procegence

Pre-Conference Focus Day

Tuesday January 28, 2020

1:00 pm | Modeling & Simulations for Continuous Manufacturing Applications

Lisa Graham
VP, Analytics Engineering
Seeq Corporation

Dr. Lisa Graham leads the Analytics Engineering team at Seeq Corporation. She holds her Ph.D. in chemical engineering and is a registered professional chemical engineer. With 20 years of experience across many industries, including pharmaceuticals and life sciences, and specialty chemicals, Lisa’s technical strengths include chemical engineering, product development, and process model development. She has a well-developed acumen in crafting process analytical technology and data analytics solutions to help drive innovation and growth, while reducing costs. Lisa has a strong business background established through C-Level leadership positions, including COO and SVP roles at Bend Research (now Lonza), and founding Alkemy Innovation in Bend, Oregon. She is actively involved in supporting higher education and specific STEM education initiatives. Specific efforts include serving as Director on the Oregon Governor's STEM Investment Council and as Chair of the Oregon Board of Trustees for Oregon Tech University.

Day One

Wednesday 29th January 2020

9:45 am | Panel Discussion: Where’s the Real Barrier to CM Implementation; Regulatory, Strategic or Economic?

Hans Johansson
Global Applications Director, Life Sciences
Purolite

Hans J Johansson is Global Applications Director at Purolite Life Sciences, Llantrisant, Wales. He has spent more than 30 years in the Biotech industry. Most of the time in research and development at Pharmacia/Amersham/GE Healthcare with a special focus on design and applications of industrial chromatography resins intended for antibody purification. He frequently publishes in scientific journals and is the holder of more than ten patents around resin design and large-scale protein purification. He is currently working with development and applications of novel, agarose-based, chromatography resins.

Stream 2 - Day 1 PM

1:30 pm | Continuous manufacturing of agarose resins and its applications

Bob Lenich
Director, Life Sciences Business
Emerson

Bob is a life-long learner who stays engaged in new technology and organizational trends in order to adapt them to solving operating issues across the process industries. He works with a wide variety of organizations to identify operational problems, evaluate how to make improvements, and then justify and sell the approach. Bob loves seeing the successful deployment of a solution and then sharing the benefits so that others can take advantage of the approach. Bob gets special gratification from seeing how those improvements help areas like Life Science manufacturing improve people’s lives. Bob currently is responsible for planning Emerson's strategy for growing our automation business in the Life Science industry globally.  He then collaboratively works across the various business units in Emerson to implement the strategy and build the business. Bob has a BS in Chemical Engineering from Rose Hulman Institute of Technology and an MBA from the University of Texas.

Mara van Haandel
Innovation Manager
DFE Pharma

Stream 1 - Day 1 PM

1:30 pm | Understanding and Accounting for Excipient Variability in Continuous Tablet Manufacturing

Wayne Nettnay
Sales Director
YMC PROCESS TECHNOLOGIES, INC.

Stream 1 - Day 2

2:45 pm | Session Reserved for YMC

Stream 2 - Day 1 PM

2:15 pm | Multi-Column Chromatography Going Mainstream

Bart Rimez
Co-owner & Technology Lead
Secoya

Stream 1 - Day 1 PM

2:15 pm | Secoya Crystallization Technology: Upscaling Crystallization Processes Using a Single Reactor Type from the Lab to Production

Gabriella Dahlgren
Senior Manager, PQM
Janseen

Day One

Wednesday 29th January 2020

9:45 am | Panel Discussion: Where’s the Real Barrier to CM Implementation; Regulatory, Strategic or Economic?

Pre-Conference Focus Day

Tuesday January 28, 2020

4:15 pm | Group Discussion: Revolutionizing Your Regulatory Strategy

Tana M Session
Founder & Chief Executive Officer
TanaMSession.com

Day One

Wednesday 29th January 2020

5:00 pm | Celebrating Half a Decade of CCP: Evening Reception Including Panel Discussion on Diversity in Pharma Manufacturing

Steven A. Lopez
Assistant Professor/Board Chair
Roux Insitute Northeastern University/Alliance for Diversity in Science and Engineering

Day One

Wednesday 29th January 2020

5:00 pm | Celebrating Half a Decade of CCP: Evening Reception Including Panel Discussion on Diversity in Pharma Manufacturing

Stephanie Joong
Engineering & Facilities Manager
Janssen

Day One

Wednesday 29th January 2020

5:00 pm | Celebrating Half a Decade of CCP: Evening Reception Including Panel Discussion on Diversity in Pharma Manufacturing

Lawrence De Belder
Continuous Processing SME
Independent

Senior Representative

GEA